MDGL · Madrigal Pharmaceuticals, Inc.
Market Cap
$12.56B
Shares
23.10M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1157601
CUSIP
558868105
13F (30d)
298 filings
295 filers
Visit website
Investor relations